CNTA logo

Centessa Pharmaceuticals (CNTA) Accounts payable

annual accounts payable:

$7.14M-$4.67M(-39.54%)
December 31, 2024

Summary

  • As of today (July 1, 2025), CNTA annual accounts payable is $7.14 million, with the most recent change of -$4.67 million (-39.54%) on December 31, 2024.
  • During the last 3 years, CNTA annual accounts payable has fallen by -$922.00 thousand (-11.43%).
  • CNTA annual accounts payable is now -48.37% below its all-time high of $13.84 million, reached on December 31, 2022.

Performance

CNTA Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAbalance sheet metrics

quarterly accounts payable:

$5.13M-$2.01M(-28.15%)
March 31, 2025

Summary

  • As of today (July 1, 2025), CNTA quarterly accounts payable is $5.13 million, with the most recent change of -$2.01 million (-28.15%) on March 31, 2025.
  • Over the past year, CNTA quarterly accounts payable has dropped by -$2.37 million (-31.56%).
  • CNTA quarterly accounts payable is now -72.19% below its all-time high of $18.46 million, reached on September 30, 2021.

Performance

CNTA quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCNTAbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

CNTA Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-39.5%-31.6%
3 y3 years-11.4%-23.3%
5 y5 years--

CNTA Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-48.4%at low-64.3%at low
5 y5-year-48.4%+592.1%-72.2%at low
alltimeall time-48.4%>+9999.0%-72.2%at low

CNTA Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$5.13M(-28.2%)
Dec 2024
$7.14M(-39.5%)
$7.14M(-4.0%)
Sep 2024
-
$7.44M(+39.9%)
Jun 2024
-
$5.32M(-29.1%)
Mar 2024
-
$7.50M(-36.5%)
Dec 2023
$11.81M(-14.6%)
$11.81M(+8.9%)
Sep 2023
-
$10.85M(-2.1%)
Jun 2023
-
$11.09M(-22.8%)
Mar 2023
-
$14.37M(+3.8%)
Dec 2022
$13.84M
$13.84M(+27.4%)
Sep 2022
-
$10.86M(+31.9%)
Jun 2022
-
$8.23M(+23.0%)
DateAnnualQuarterly
Mar 2022
-
$6.69M(-17.1%)
Dec 2021
$8.06M(+681.5%)
$8.06M(-56.3%)
Sep 2021
-
$18.46M(+154.2%)
Jun 2021
-
$7.26M(-40.6%)
Mar 2021
-
$12.22M
Dec 2020
$1.03M(-59.4%)
-
Jun 2020
$2.54M(-7.1%)
-
Jun 2019
$2.74M(+63.4%)
-
Jun 2018
$1.67M(-28.1%)
-
Jun 2017
$2.33M(+88.0%)
-
Jun 2016
$1.24M(+8872.5%)
-
Jun 2015
$13.80K
-

FAQ

  • What is Centessa Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Centessa Pharmaceuticals?
  • What is Centessa Pharmaceuticals annual accounts payable year-on-year change?
  • What is Centessa Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Centessa Pharmaceuticals?
  • What is Centessa Pharmaceuticals quarterly accounts payable year-on-year change?

What is Centessa Pharmaceuticals annual accounts payable?

The current annual accounts payable of CNTA is $7.14M

What is the all time high annual accounts payable for Centessa Pharmaceuticals?

Centessa Pharmaceuticals all-time high annual accounts payable is $13.84M

What is Centessa Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, CNTA annual accounts payable has changed by -$4.67M (-39.54%)

What is Centessa Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of CNTA is $5.13M

What is the all time high quarterly accounts payable for Centessa Pharmaceuticals?

Centessa Pharmaceuticals all-time high quarterly accounts payable is $18.46M

What is Centessa Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, CNTA quarterly accounts payable has changed by -$2.37M (-31.56%)
On this page